Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03085264 · ClinicalTrials.gov registry record · NA

Community Health Worker Care Transitions Study

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
600
Enrollment target

NCT03085264: Completed NA study, sponsored by Massachusetts General Hospital.

NCT03085264 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03085264, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
600 participants
Enrollment target

Study Summary

This study focuses on pairing community health workers (CHWs) with patients that are high risk for readmission prior to hospital discharge in order to assess differences in hospital readmission rates, ED visits, patient satisfaction and provider satisfaction as compared to patients without community health worker pairings at discharge.

Primary Outcome

The number of patients readmitted within 30 days of being discharged from studied medical units during a given month/ the number of patients discharged from studied medical units during a given month

Interventions

  • BEHAVIORAL Community Health Worker

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2017-04-07
Est. Completion 2019-10-30
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT03085264 record still lists

NCT03085264 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).

The record links to 0 conditions, and to 1 intervention - of which Community Health Worker is the first listed.

NCT03085264 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03085264 about?

NCT03085264 is a clinical study titled "Community Health Worker Care Transitions Study". This study focuses on pairing community health workers (CHWs) with patients that are high risk for readmission prior to hospital discharge in order to assess differences in hospital readmission rates, ED visits, patient satisfaction and provider satisfaction as compared to patients without community...

What is the current status of trial NCT03085264?

This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2017-04-07. Estimated completion is 2019-10-30.

What interventions are being tested in trial NCT03085264?

The interventions under investigation include: Community Health Worker (BEHAVIORAL).

Who is sponsoring clinical trial NCT03085264?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03085264's enrollment target sits among peer trials

600 162nd of 2000 higher than 1,827 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03085264, the US trial registry maintained by the National Library of Medicine. NCT03085264 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.